On July 22, 2026, multiple financial institutions issued rating and price target updates for Super Micro Computer, Inc., amid robust AI server demand.
3 reports, 2 independent
Updated Oct 14
Gone quiet
- Reports
- 3
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
On July 22, 2026, multiple financial institutions issued rating and price target updates for Super Micro Computer, Inc., amid robust AI server demand.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.CEO Charles Liang sold shares as Citigroup and Raymond James Financial updated their ratings for Super Micro Computer.1 source
Mizuho Securities updated its price target for SMCI stock.1 source
Rating updates on SMCI from Goldman Sachs, Barclays, Raymond James, and Needham.1 source
Keep exploring
The entities involved
-
Goldman Sachs
American investment bank
-
Reuters
international news agency
-
Barclays
British bank
-
Raymond James Financial
American Investment Bank and Financial Services Firm
Related events
- Several financial firms, including Raymond James Financial and Truist Financial, issued multiple rating and price target updates on November 6, 2026.
- Goldman Sachs and HSBC issued rating updates citing high input costs for Asian Paints.
- Multiple financial firms, including Raymond James, Wells Fargo, UBS, Cantor Fitzgerald, and KeyCorp, issued rating updates and target price changes on November 2, 2026.
- Banks like Mizuho, Deutsche Bank, and Goldman Sachs maintained or raised ratings for Harmony Biosciences, citing benefits from tariffs and onshoring trends for AI stocks.
- Raymond James Financial reaffirmed a strong-buy rating and Morgan Stanley set a $25.00 price objective for VIR Biotechnology.